TP53 and neuroendocrine carcinoma: Classification of uncommon grade 3 NEN without classic features of NEC is problematic in the most recent WHO classification, and our data suggest that these tumors may be biologically distinct from NEC, or, alternatively, that they fall along a spectrum of heterogeneous LCNEC that lack p53 and RB alterations.